Skip to main content

Table 5 Procedure-related complications and 30-day outcomes

From: Long-term outcomes of concomitant tricuspid valve repair in patients undergoing mitral valve surgery

 

Isolated MVS (N = 182)

MVS + TVR (N = 182)

P-value

Procedure-related complications

 Postoperative mortality, %

1.6

1.1

1.000

 Wound infection, %

3.3

3.3

1.000

 Pericardial tamponade, %

6.6

8.2

0.548

 AV block grade III, %

9.3

14.3

0.144

 Pneumonia, %

8.2

11.0

0.374

 Pneumothorax, %

0.5

0.5

1.000

 Pleural effusion, %

3.3

6.0

0.214

 Atrial Fibrillation, %

29.3

34.6

0.276

30-day complications

 Death, %

7.7

5.5

0.398

  CV death, %

4.9

3.3

0.429

  Non-CV death, %

2.7

2.2

1.000

 Stroke, %

7.1

3.8

0.168

 Acute renal failure, %

12.2

12.6

0.889

 Myocardial infarction, %

0

0

n.a.

 Pacemaker implantation, %

8.8

16.0

0.037

 Repeat MV surgery, %

1.1

0.5

1.000

  1. Legend: values are percentage or median [interquartile range]
  2. AV atrioventricular, CV cardiovascular, MV mitral valve, MVS mitral valve surgery, TVR tricuspid valve repair